Gold Standard Diagnostics Release: Boost Clinical Lab Efficiency With the ThunderBolt® EIA+CLIA Automation Platform
7/17/2012 9:48:06 AM
LOS ANGELES--(BUSINESS WIRE)--Gold Standard Diagnostics (GSD) today announced the addition of fully-automated Chemiluminescence Immunoassay (CLIA) processing capability to the powerful ThunderBolt® Automation Platform. With the ability to simultaneously automate CLIA alongside EIA, laboratories of any size can now achieve even more dramatic increases in throughput, flexibility and cost savings. The CLIA enhancement firmly establishes the ThunderBolt® as the most full-featured, compact analyzer on the market. See the ThunderBolt® in action at the 2012 AACC Lab Expo, booth #2222 in the Los Angeles Convention Center from July 17th-19th.
comments powered by